Gilead Sciences (GILD) Misses Q3 EPS by 11c; Reiterates Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
UPDATE: BMO Capital Maintains Gilead Sciences (GILD) at Market Perform (Correction)
November 2, 2016 6:56 AM EDT(Updated - November 2, 2016 7:17 AM EDT)
(Gilead was not upgraded to Outperform, remains Market Perform at BMO.)
BMO Capital maintained its Market Perform rating on Gilead Sciences (NASDAQ: GILD) with a price target of $84 (prior $98). Comments follow Q3 results.... More
Gilead Sciences (GILD) Declares $0.47 Quarterly Dividend; 2.5% Yield
November 1, 2016 4:04 PM EDTGilead Sciences (NASDAQ: GILD) declared a quarterly dividend of $0.47 per share, or $1.88 annualized.
The dividend will be payable on December 29, 2016, to stockholders of record on December 15, 2016, with an ex-dividend date of December 13, 2016.
The annual yield on the dividend is 2.5... More
